Joanna M. D.
- Country
- Poland
- Department
- Pulmonology
Research Overview
- Phase 2a Randomized, Double‑Blind, Placebo‑Controlled Study of Subcutaneous SAR445399 on Mucus Plug Score in Adults with Non‑Cystic Fibrosis Bronchiectasis
- Efficacy, Safety, and Tolerability of Itepekimab in Non-Cystic Fibrosis Bronchiectasis: A Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Long-term Safety and Efficacy of Avacopan in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Data & Insights
Has run more than one trial at 16 of 76 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in treating non-cystic fibrosis bronchiectasis (NCFB), a chronic respiratory condition characterized by permanent airway damage.
- Bronchiectasis Management
- Pulmonary Exacerbations
- Respiratory Inflammation
Focused on evaluating novel therapeutic approaches for bronchiectasis treatment through antibody-based interventions.
Immunotherapy
Conducts research in monoclonal antibody therapeutics, particularly investigating treatments targeting specific inflammatory pathways in respiratory diseases.
- Targeted Antibody Therapy
- Anti-inflammatory Treatment
- Immune Response Modulation
Explores innovative immunological approaches for chronic respiratory conditions.
Clinical Therapeutics
Specializes in proof-of-concept studies evaluating the efficacy and safety of novel therapeutic agents for respiratory disorders.
- Drug Safety Assessment
- Treatment Tolerability
- Clinical Outcomes Research
Focuses on developing evidence-based therapeutic strategies for chronic respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.